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INTRODUCTION ABOUT HERBAL DRUGS 
The term “medicinal plant” include various types of plants used in herbalism 
("herbology" or "herbal medicine"). It is the use of plants for medicinal purposes, and 
the study of such uses. The word “herb” has been derived from the Latin 
word, “herba” and an old French word “herbe”. Now days, herb refers to any part of 
the plant like fruit, seed, stem, bark, flower, leaf, stigma or a root, as well as a non-
woody plant. Earlier, the term “herb” was only applied to non-woody plants, including 
those that come from trees and shrubs. These medicinal plants are also used as 
food, flavonoid, medicine or perfume and also in certain spiritual activities. 
Plants have been used for medicinal purposes long before prehistoric period. Ancient 
Unani manuscripts Egyptian papyrus and Chinese writings described the use of 
herbs.  Evidence exist that Unani Hakims, Indian Vaids and European and 
Mediterranean cultures were using herbs for over 4000 years as medicine. 
Indigenous cultures such as Rome, Egypt, Iran, Africa and America used herbs in 
their healing rituals, while other developed traditional medical systems such as 
Unani, Ayurveda and Chinese Medicine in which herbal therapies were used 
systematically. 
Traditional systems of medicine continue to be widely practiced on many accounts. 
Population rise, inadequate supply of drugs, prohibitive cost of treatments, side 
effects of several synthetic drugs and development of resistance to currently used 
drugs for infectious diseases have led to increased emphasis on the use of plant 
materials as a source of medicines for a wide variety of human ailments. 
Among ancient civilizations, India has been known to be rich repository of medicinal 
plants. The forest in India is the principal repository of large number of medicinal and 
aromatic plants, which are largely collected as raw materials for manufacture of drugs 
and perfumery products. About 8,000 herbal remedies have been codified in AYUSH 
systems in INDIA. Ayurveda, Unani, Siddha and Folk (tribal) medicines are the major 
systems of indigenous medicines. Among these systems, Ayurveda and Unani 
Medicine are most developed and widely practiced in India. 
Recently, WHO (World Health Organization) estimated that 80 percent of people 
worldwide rely on herbal medicines for some aspect of their primary health care 
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needs. According to WHO, around 21,000 plant species have the potential for being 
used as medicinal plants. 
As per data available over three-quarters of the world population relies mainly on 
plants and plant extracts for their health care needs. More than 30% of the entire 
plant species, at one time or other were used for medicinal purposes. It has been 
estimated, that in developed countries such as United States, plant drugs constitute 
as much as 25% of the total drugs, while in fast developing countries such as India 
and China, the contribution is as much as 80%. Thus, the economic importance of 
medicinal plants is much more to countries such as India than to rest of the world. 
These countries provide two third of the plants used in modern system of medicine 
and the health care system of rural population depend on indigenous systems of 
medicine. 
Treatment with medicinal plants is considered very safe as there is no or minimal 
side effects. These remedies are in sync with nature, which is the biggest advantage. 
The golden fact is that, use of herbal treatments is independent of any age groups 
and the sexes. 
The ancient scholars only believed that herbs are only solutions to cure a number of 
health related problems and diseases. They conducted thorough study about the 
same, experimented to arrive at accurate conclusions about the efficacy of different 
herbs that have medicinal value. Most of the drugs, thus formulated, are free of side 
effects or reactions. This is the reason why herbal treatment is growing in popularity 
across the globe. These herbs that have medicinal quality provide rational means for 
the treatment of many internal diseases, which are otherwise considered difficult to 
cure. 
Medicinal plants such as Aloe, Tulsi, Neem, Turmeric and Ginger cure several 
common ailments. These are considered as home remedies in many parts of the 
country. It is known fact that lots of consumers are using Basil (Tulsi) for making 
medicines, black tea, in Pooja and other activities in their day to day life. 
In several parts of the world many herbs are used to honour their kings showing it as 
a symbol of luck. Now, after finding the role of herbs in medicine, lots of consumers 
started the plantation of tulsi and other medicinal plants in their home gardens. 
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Medicinal plants are considered as a rich resources of ingredients which can be used 
in drug development either pharmacopoeial, non- pharmacopoeial or synthetic drugs. 
A part from that, these plants play a critical role in the development of human cultures 
around the whole world. Moreover, some plants are considered as important source 
of nutrition and as a result of that they are recommended for their therapeutic values. 
Some of these plants include ginger, green tea, walnuts, aloe, pepper and turmeric 
etc. Some plants and their derivatives are considered as important source for active 
ingredients which are used in aspirin and toothpaste etc. 
Apart from the medicinal uses, herbs are also used in natural dye, pest control, food, 
perfume, tea and so on. In many countries different kinds of medicinal plants/ herbs 
are used to keep ants, flies, mice and flee away from homes and offices. Now a day’s 
medicinal herbs are important sources for pharmaceutical manufacturing. 
Recipes for the treatment of common ailments such as diarrhoea, constipation, 
hypertension, low sperm count, dysentery and weak penile erection, piles, coated 
tongue, menstrual disorders, bronchial asthma, leucorrhoea and fevers are given by 
the traditional medicine practitioners very effectively. 
Over the past two decades, there has been a tremendous increase in the use of 
herbal medicine; however, there is still a significant lack of research data in this field. 
Therefore, since 1999, WHO has published three volumes of the WHO monographs 
on selected medicinal plants. 
Importance of some herbs with their medicinal values 
 Herbs such as black pepper, cinnamon, myrrh, aloe, sandalwood, ginseng, red 
clover, burdock, bayberry, and safflower are used to heal wounds, sores and 
boils. 
 Basil, Fennel, Chives, Cilantro, Apple Mint, Thyme, Golden Oregano, 
Variegated Lemon Balm, Rosemary, Variegated Sage are some important 
medicinal herbs and can be planted in kitchen garden. These herbs are easy 
to grow, look good, taste and smell amazing and many of them are magnets 
for bees and butterflies. 
 Many herbs are used as blood purifiers to alter or change a long-standing 
condition by eliminating the metabolic toxins. These are also known as 'blood 
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cleansers'. Certain herbs improve the immunity of the person, thereby 
reducing conditions such as fever. 
 Some herbs are also having antibiotic properties. Turmeric is useful in 
inhibiting the growth of germs, harmful microbes and bacteria. Turmeric is 
widely used as a home remedy to heal cut and wounds. 
 To reduce fever and the production of heat caused by the condition, certain 
antipyretic herbs such as Chirayta, black pepper, sandal wood and safflower 
are recommended by traditional Indian medicine practitioners. 
 Sandalwood and Cinnamon are great astringents apart from being aromatic. 
Sandalwood is especially used in arresting the discharge of blood, mucus etc. 
 Some herbs are used to neutralize the acid produced by the stomach. Herbs 
such as marshmallow root and leaf. They serve as antacids. The healthy 
gastric acid needed for proper digestion is retained by such herbs. 
 Indian sages were known to have remedies from plants which act against 
poisons from animals and snake bites. 
 Herbs like Cardamom and Coriander are renowned for their appetizing 
qualities. Other aromatic herbs such as peppermint, cloves and turmeric add a 
pleasant aroma to the food, thereby increasing the taste of the meal. 
 Some herbs like aloe, sandalwood, turmeric, sheet raj hindi and khare khasak 
are commonly used as antiseptic and are very high in their medicinal values. 
 Ginger and cloves are used in certain cough syrups. They are known for their 
expectorant property, which promotes the thinning and ejection of mucus from 
the lungs, trachea and bronchi. Eucalyptus, Cardamom, Wild cherry and 
cloves are also expectorants. 
 Herbs such as Chamomile, Calamus, Ajwain, Basil, Cardamom, 
Chrysanthemum, Coriander, Fennel, Peppermint and Spearmint, Cinnamon, 
Ginger and Turmeric are helpful in promoting good blood circulation. 
Therefore, they are used as cardiac stimulants. 
 Certain medicinal herbs have disinfectant property, which destroys disease 
causing germs. They also inhibit the growth of pathogenic microbes that cause 
communicable diseases. 
 Herbal medicine practitioners recommend calmative herbs, which provide a 
soothing effect to the body. They are often used as sedatives. 
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 Certain aromatic plants such as Aloe, Golden seal, Barberry and Chirayata are 
used as mild tonics. The bitter taste of such plants reduces toxins in blood. 
They are helpful in destroying infection as well. 
 Certain herbs are used as stimulants to increase the activity of a system or an 
organ, for example herbs like Cayenne (Lal Mirch, Myrrh, Camphor and 
Guggul). 
  A wide variety of herbs including Giloe, Golden seal, Aloe and Barberry are 
used as tonics. They can also be nutritive and rejuvenate a healthy as well as 
diseased individual. 
 Honey, turmeric, marshmallow and liquorice can effectively treat a fresh cut 
and wound. They are termed as vulnerary herbs. 
As our lifestyle is now getting techno-savvy, we are moving away from nature. While 
we cannot escape from nature because we are part of nature. As herbs are natural 
products they are free from side effects, they are comparatively safe, eco-friendly and 
locally available. Traditionally there are lot of herbs used for the ailments related to 
different seasons. There is a need to promote them to save the human lives. 
These herbal products are today being the symbol of safety in contrast to the 
synthetic drugs, that are regarded as unsafe to human being and environment. 
Although herbs had been priced for their medicinal, flavouring and aromatic qualities 
for centuries, the synthetic products of the modern age surpassed their importance, 
for a while. However, the blind dependence on synthetics is over and people are 
returning to the naturals with hope of safety and security. It’s time to promote them 
globally.64 
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1.1. ASTHMA 
Asthma is a chronic inflammatory lung disease that can cause repeated 
episodes of cough, wheezing and breathing difficulty. 
During an acute asthma episode, the airway lining in the lungs becomes 
inflamed and swollen. In addition, mucus production occurs in the airway and 
muscles surrounding the airway spasm. Combined, these cause a reduction in air 
flow. 1 
1.1.1. Asthma is characterized by:  
 Airway inflammation: The airway lining becomes red, swollen, and narrow.  
 Airway obstruction: The muscles encircling the airway tighten causing the 
airway to narrow making it difficult to get air in and out of the lungs. 
 Airway hyper-responsiveness: The muscles encircling the airway respond 
more quickly and vigorously to small amounts of allergens and irritants.    
1.1.2. Common signs and symptoms of an acute asthma episode include:  
• Coughing 
• Wheezing  
• Breathlessness  
• Respiratory rate increased 
• Chest tightness  
• Chest or abdominal pain  
• Fatigue, feeling out of breath  
• Agitation   
• Increased pulse rate 
1.1.3. Causes 
 Allergens from nature, typically inhaled, which include waste from common 
household pests. 
 Indoor air pollution from volatile organic compounds. 
 Medications, aspirin,βadrenergic antagonists (beta blockers), and penicillin. 
 Food allergies such as milk, peanuts, and eggs. 
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1.1.4. Pathophysiology and pathogenesis of asthma 
Airflow limitation in asthma is recurrent and caused by a variety of changes in the 
airway. These include: 
 Bronchoconstriction 
In asthma, the dominant physiological event leading to clinical symptoms is 
airway narrowing and a subsequent interference with airflow. In acute 
exacerbations of asthma, bronchial smooth muscle contraction 
(bronchoconstriction) occurs quickly to narrow the airways in response to 
exposure to a variety of stimuli including allergens or irritants. Allergen-induced 
acute bronchoconstriction results from an IgE-dependent release of mediators 
from mast cells that includes histamine, tryptase, leukotrienes and prostaglandins 
that directly contract airway smooth muscle. 
 Airway edema 
  As the disease becomes more persistent and inflammation more progressive, 
other factors further limit airflow. These include edema, inflammation, mucus 
hypersecretion and the formation of inspissated mucus plugs, as well as structural 
changes including hypertrophy and hyperplasia of the airway smooth muscle. 
These latter changes may not respond to usual treatment. 
 Airway hyper responsiveness 
This is an exaggerated bronchoconstrictor response to a wide variety of stimuli 
is a major, but not necessarily unique, feature of asthma. 
 Airway remodeling 
 
In some persons who have asthma, airflow limitation may be only partially 
reversible. Permanent structural changes can occur in the airway; these are 
associated with a progressive loss of lung function that is not prevented by or fully 
reversible by current therapy. Airway remodeling involves an activation of many of 
the structural cells, with consequent permanent changes in the airway that 
increase airflow obstruction and airway responsiveness and render the patient 
less responsive to therapy.2 
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1.1.5. Pathophysiologic mechanism in the development of air way inflammation 
Inflammation has a central role in the pathophysiology of asthma. As noted in 
the definition of asthma, airway inflammation involves an interaction of many cell 
types and multiple mediators with the airways that eventually results in the 
characteristics pathophysiologic features of the disease, bronchial inflammation and 
airflow limitation that result in current episodes of cough, wheeze, and shortness of 
breath. The process by which these interactive events occur and leads to asthma are 
still under investigation. The pattern of airway inflammation in asthma, however does 
not necessarily vary depending upon the disease severity, persistence and duration 
of disease. The cellular profile and the response of the structural cells in asthma are 
quite consistent.3 
1.1.6. Inflammatory Cells 
• Lymphocytes 
An increased understanding of the development and regulation of airway 
inflammation in asthma followed the discovery and description of subpopulations 
of lymphocytes, T helper1 cells and T helper2 cells with distinct inflammatory 
mediator profiles and asthma as a Th2 disease, recognizing the importance of 
number of families of cytokines and chemokines has advanced our understanding 
of the development of airway inflammation effects on airway function. After the 
discovery of these distinct lymphocyte subpopulations in animal models of allergic 
inflammation, evidence emerged that, in human asthma, a shift, or predilection, 
toward the Th2-cytokine profile resulted in the eosinophilic inflammation 
characteristic of asthma. In addition, generation of Th2 cytokines (e.g., interleukin-
4 (IL-4), IL-5 and IL-3) could also explain the overproduction of IgE, presence of 
eosinophils, and development of airway hyperresponsiveness. There also may be 
a reduction in a subgroup of lymphocytes, regulatory T cells, which normally 
inhibit Th2 cells, as well as an increase in natural killer (NK) cells that release 
large amounts of Th1 and Th2 cytokines. T lymphocytes, along with other airway 
resident cells, also can determine the development and degree of airway 
remodeling. 
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• Mast cells 
Activation of mucosal mast cells releases bronchoconstrictor mediators 
(histamine, cysteinyl-leukotrienes, prostaglandin D2). Although allergen activation 
occurs through high affinity IgE receptors and is likely the most relevant reaction, 
sensitized mast cells also may be activated by osmotic stimuli to account for 
exercise induced bronchospasm (EIB). Increased number of mast cells in airway 
smooth muscle may be linked to airway hyperresponsiveness. Mast cells also can 
release a large number of cytokines to change the airway environment and 
promote inflammation even though exposure to allergens is limited. 
• Eosinophils 
Increased numbers of eosinophils exist in the airways of most, but not all, persons 
who have asthma. These cells contain inflammatory enzymes, generate 
leukotrienes, and express a wide variety of pro-inflammatory cytokines. Increases 
in eosinophils often correlate with greater asthma severity. In addition, numerous 
studies show that treating asthma with corticosteroids reduces circulating and 
airway eosinophils in parallel with clinical improvement. However, the role and 
contribution of eosinophils to asthma is undergoing a reevaluation based on 
studies with an anti-IL-5 treatment that has significantly reduced eosinophils but 
did not affect asthma control. Therefore, although the eosinophil may not be the 
only primary effector cell in asthma, it likely has a distinct role in different phases 
of the disease. 
• Neutrophils 
Neutrophils are increased in the airways and sputum of persons who have severe 
asthma, during acute exacerbations, and in the presence of smoking. Their 
pathophysiological role remains uncertain; they may be a determinant of a lack of 
response to corticosteroid treatment. The regulation of neutrophil recruitment, 
activation, and alteration in lung function is still under study, but leukotriene 
B4 may contribute to these processes. 
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• Dendritic cells 
These cells function as key antigen-presenting cells that interact with allergens 
from the airway surface and then migrate to regional lymph nodes to interact with 
regulatory cells and ultimately to stimulate Th2 cell production from naive T cells. 
 
 Macrophages 
Macrophages are the most numerous cells in the airways and also can be 
activated by allergens through low-affinity IgE receptors to release inflammatory 
mediators and cytokines that amplify the inflammatory response.4 
1.1.7. Inflammatory mediators 
 Chemokines are important in recruitment of inflammatory cells into the airways 
and are mainly expressed in airway epithelial cells. Eotaxin is relatively selective 
for eosinophils, whereas thymus and activation-regulated chemokines (TARCs) 
and macrophage-derived chemokines (MDCs) recruit Th2 cells. There is an 
increasing appreciation for the role this family of mediators has in orchestrating 
injury, repair, and many aspects of asthma. 
 Cytokines direct and modify the inflammatory response in asthma and likely 
determine its severity. Th2-derived cytokines include IL-5, which is needed for 
eosinophil differentiation and survival, and IL-4 which is important for Th2 cell 
differentiation and with IL-13 is important for IgE formation. Key cytokines include 
IL-1β and tumor necrosis factor-α (TNF-α), which amplify the inflammatory 
response, and granulocyte-macrophage colony-stimulating factor (GM-CSF), 
which prolongs eosinophil survival in airways. Recent studies of treatments 
directed toward single cytokines (e.g., monoclonal antibodies against IL-5 or 
soluble IL-4 receptor) have not shown benefits in improving asthma outcomes. 
 Cysteinyl-leukotrienes are potent bronchoconstrictors derived mainly from mast 
cells. They are the only mediator whose inhibition has been specifically 
associated with an improvement in lung function and asthma symptoms. Recent 
studies have also shown leukotriene B4 can contribute to the inflammatory 
process by recruitment of neutrophils. 
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 Nitric oxide (NO) is produced predominantly from the action of inducible NO 
synthase in airway epithelial cells; it is a potent vasodilator. Measurements of 
fractional exhaled NO 
(FeNO) may be useful for monitoring response to asthma treatment because of 
the purported association between FeNO and the presence of inflammation in 
asthma). 
 Immunoglobulin E (IgE) is the antibody responsible for activation of allergic 
reactions and is important to the pathogenesis of allergic diseases and the 
development and persistence of inflammation. IgE attaches to cell surfaces via a 
specific high-affinity receptor. The mast cell has large numbers of IgE receptors; 
these, when activated by interaction with antigen, release a wide variety of 
mediators to initiate acute bronchospasm and also to release pro-inflammatory 
cytokines to perpetuate underlying airway inflammation.5 
1.1.8. Treatment 
There are number of treatments that can help effectively control or sooth the 
asthmatic condition. Treatment is based on two important goals, which are (i) specific 
regimens for the treatment of acute attack by opening swollen airways that are 
limiting breathing and (ii) prophylactic measures to reduce the inflammation and 
airway resistance and to maintain airflow. Treatment and prevention involves a 
combination of medicines, life style advices and identifying and then avoiding 
potential asthma triggers. 
Drugs which are indicated for the treatment of asthma includes the classes of 
beta2 agonists, corticosteroids, leukotriene inhibitors and xanthenes. They are 
available in the forms of inhalations, tablets, capsules and injections are used based 
on medical condition and supervision. Inhalation preparation includes solutions for 
nebulization, metered dose inhalers and powdered inhalers. Asthma medicines are 
usually given by inhalers, which are the devices that deliver the drug directly into the 
airways through your mouth when you breathe. 
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Drugs for treating asthma are divided into two categories: (1) Quick-relief 
medications (which are used to relief acute asthma) and (2) Long-term asthma 
control medications (which are used as prophylactic measures). 
1. Quick-relief medications: they are used as needed for rapid, short-term symptom 
relief during an asthma attack. Types of quick-relief medications are 
a) Short-acting beta2 agonists: these inhaled, quick-relief bronchodilators act 
within minutes to rapidly ease symptoms during an asthma attack. Short-
acting beta2 agonists can be taken using a portable, hand-held inhaler or a 
nebulizer. Examples are salbutamol and terbutaline. 
b) Antimuscarinics: these inhaled antimuscarinics act quickly to immediately relax 
the airways, like other bronchodilators, making it easier to breathe. Examples 
are ipratropium and tiotropium. 
c) Systemic corticosteroids: these systemic corticosteroids (i.e., oral and 
intravenous routes) relieve airway inflammation caused by severe asthma. 
However, due to serious side effects when used long term, the systemic 
routes are used only on a short-term basis to treat severe asthma symptoms. 
Examples are prednisone and methyl prednisone. 
d) Intravenous xanthines: these xanthines relax smooth muscle and to relieve 
bronchial spasm and are indicated for severe asthma attack. Example is 
aminophylline. 
2. Long-term asthma control medications: they work to reduce the amount of 
inflammation in the airways and prevent asthma attacks occurring. 
 
a) Inhaled corticosteroids: they are the most effective preventers, however, you 
may need to use these medications for several days to weeks before they 
reach their maximum benefit. Examples are fluticasone and budesonide. 
b) Long-acting beta2 agonists: these inhaled medications open the airways. 
Some research shows that they may increase the risk of a severe asthma 
attack, unless they are used in combination with an inhaled corticosteroid. 
Examples are salmeterol and formoterol. 
c) Leukotriene inhibitors: they act against one of the inflammatory components of 
asthma and provide protection against bronchoconstriction when taken before 
Introduction 
 
Page | 13 
exercise or exposure to allergen or to cold air. Examples of leukotriene 
inhibitors include montelukast and zafirlukast. 
d) Xanthines : apart from the relaxiation of bronchial muscle and bronchial spasm 
they can stimulant effect on respiration and have anti-inflammatory effects. 
Example is theophylline.6 
 
1.2. INFLAMMATION 
 Inflammation is defined as the local response of living mammalian tissue to 
injury due to any agent. It is a body defense reaction in order to eliminate or limit the 
spread of injurious agent. 
1.2.1. Causes of inflammation 
 Infective agents. E.g.: Bacteria, viruses and their toxins. 
 Immunological agents. E.g.: Cell mediated and antigen antibody reaction. 
 Physical agents. E.g.: Heat, cold, radiation, mechanical trauma. 
 Chemical agents. E.g.: Organic and inorganic poisons 
1.2.2. Signs of inflammation 
The main signs of inflammation are 
 Redness (Latin rubor) 
 Heat (calor) 
 Swelling (tumor) 
 Pain (dolor) 
1.2.3. Inflammation may be classified as 
      A) Acute inflammation 
      B) Chronic inflammation 
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A. Acute inflammation 
   Acute inflammation is immediate and early response to tissue. Main features are 
listed below 
       a) Vasodilation 
       b) Vascular leakage and edema 
       c) Leukocyte emigration 
a) Vasodilation 
Brief arteriolar vasoconstriction followed by vasodilation 
 Accounts for warmth and redness. 
 Opens microvascular beds. 
 Increased intravascular pressure causes an early transudate into interstitium. 
 
b) Vascular leakage 
 Transudate gives way to exudate (protein‐rich)  
 Increases interstitial osmotic pressure contributing to edema (water and ions) 
Five mechanisms known to cause vascular leakiness 
1. Histamines, bradykinins, leukotrienes cause an earl, brief (15-30 min) 
immediate transient response, in the form of endothelial cell contraction that widens 
intercellular gaps of venules. 
2. Cytokines mediators (TNF, IL-1) induce endothelial junction retraction through 
cytoskeleton reorganization. 
3. Severe injuries may cause immediate direct endothelial cell damage (necrosis, 
detachment) making them leaky until they are repaired (immediate sustained 
response), or may cause delayed damage as in thermal or UV injury. 
4. Marginating and endothelial cell adherent leukocytes may pile-up and damage the 
endothelium through activation and release of toxic oxygen radicals and proteolytic 
enzymes. 
5.  Some bacterial toxins.7 
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c) Leucocyte emigration 
Leukocytes leave the vasculature routinely through the following sequence of events: 
 Margination and rolling 
 Adhesion and transmigration 
 Chemotaxis and activation 
Chemical mediators 
• Plasma‐derived: 
 Complement, kinins, coagulation factors  
 Many in “pro‐form” requiring activation (enzymatic cleavage) 8 
• Cell‐derived: 
 Preformed, sequestered and released (mast cell histamine)  
 Synthesized as needed (prostaglandin)9 
B. Chronic inflammation 
Chronic inflammation is defined as prolonged process in which tissue 
destruction and inflammation occurs at the same time. The characteristic features of 
chronic inflammation are the presence of chronic inflammatory cells such as 
lymphocytes, plasma cells and macrophages.10 
Causes of chronic inflammation 
 Chronic inflammation following acute inflammation 
 Recurrent attacks of chronic inflammation 
Characteristic features 
 Necrosis 
 Mononuclear cell infiltration 
 Proliferative changes 
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Types of chronic inflammation 
a. Non specific 
This type of chronic inflammation is occurred with the formation of granulation 
tissue E.g: chronic ulcer. 
b. Specific 
       When the injurious agent causes a characteristic histologic tissue response  
       E.g: syphilis11 
Granulomatous inflammation  
 Granuloma is defined as the tiny lesion about 1 mm diameter, composed 
predominantly of collection of modified macrophages called epithelioid cells and 
rimmed at periphery by lymphoid cells. 
Examples of granulomatous Inflammation-Tuberculosis, leprosy, fungal infections.12
  
1.3. ANTIOXIDANTS 
The ability to utilize oxygen has provided humans with the benefit of 
metabolizing fats, proteins, and carbohydrates for energy; however, it does not come 
without cost. Oxygen is a highly reactive atom that is capable of becoming part of 
potentially damaging molecules commonly called “free radicals.” Free radicals are 
capable of attacking the healthy cells of the body, causing them to lose their structure 
and function.13 
Cell damage caused by free radicals appears to be a major contributor to 
aging and to degenerative diseases of aging such as cancer, cardiovascular disease, 
cataracts, immune system decline, and brain dysfunction. Overall, free radicals have 
been implicated in the pathogenesis of at least 50 diseases. Fortunately, free radical 
formation is controlled naturally by various beneficial compounds known as 
antioxidants. It is when the availability of antioxidants is limited that this damage can 
become cumulative and debilitating.14 
Free radicals are electrically charged molecules, i.e., they have an unpaired 
electron, which causes them to seek out and capture electrons from other 
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substances in order to neutralize themselves. Although the initial attack causes the 
free radical to become neutralized, another free radical is formed in the process, 
causing a chain reaction to occur. And until subsequent free radicals are deactivated, 
thousands of free radical reactions can occur within seconds of the initial reaction. 
Antioxidants are capable of stabilizing, or deactivating, free radicals before they 
attack cells. Antioxidants are absolutely critical for maintaining optimal cellular and 
systemic health and well-being.15 
1.3.1. Reactive oxygen species 
Reactive oxygen species (ROS) is a term which encompasses all highly reactive, 
oxygen-containing molecules, including free radicals. Types of ROS include the 
hydroxyl radical, the superoxide anion radical, hydrogen peroxide, singlet oxygen, 
nitric oxide radical, hypochlorite radical, and various lipid peroxides. All are capable 
of reacting with membrane lipids, nucleic acids, proteins and enzymes, and other 
small molecules, resulting in cellular damage.16 
ROS are generated by a number of pathways. Most of the oxidants produced 
by cells occur as: 
 • A consequence of normal aerobic metabolism: approximately 90% of the 
oxygen utilized by the cell is consumed by the mitochondrial electron transport 
system. 
 • Oxidative burst from phagocytes (white blood cells) as part of the 
mechanism by which bacteria and viruses are killed, and by which foreign proteins 
(antigens) are denatured. 
 • Xenobiotic metabolism, i.e., detoxification of toxic substances. 
Consequently, things like vigorous exercise, which accelerates cellular 
metabolism; chronic inflammation, infections, and other illnesses; exposure to 
allergens and the presence of “leaky gut” syndrome; and exposure to drugs or toxins 
such as cigarette smoke, pollution, pesticides, and insecticides may all contribute to 
an increase in the body’s oxidant load.17 
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1.3.2. Antioxidant protection 
 To protect the cells and organ systems of the body against reactive oxygen 
species, humans have evolved a highly sophisticated and complex antioxidant 
protection system. It involves a variety of components, both endogenous and 
exogenous in origin, that function interactively and synergistically to neutralize free 
radicals. These components include.18, 19 
 • Nutrient derived antioxidants like ascorbic acid (vitamin C), tocopherols and 
tocotrienols (vitamin E), carotenoids and other low molecular weight compounds such 
as glutathione and lipoic acid. 
• Antioxidant enzymes, e.g., superoxide dismutase, glutathione peroxidase, 
and glutathione reductase, which catalyze free radical quenching reactions.  
• Metal binding proteins, such as ferritin, lactoferrin, albumin, and 
ceruloplasmin that sequester free iron and copper ions that are capable of catalyzing 
oxidative reactions.20 
• Numerous other antioxidant phytonutrients present in a wide variety of plant 
foods. 
Table No.1: Various reactive oxygen species (ROS) and corresponding neutralizing 
antioxidants 
ROS NEUTRALIZING ANTIOXIDANTS 
Hydroxyl radical Vitamin C, glutathione, lipoic acid 
Superoxide radical Vitamin C, glutathione, flavonoids 
Hydrogen peroxide Glutathione, beta carotene, vitamin E 
Lipid peroxides Beta carotene, vitamin E, ubiquinone 
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1.3.3. Dietary antioxidants 
 Vitamin C, vitamin E, and beta carotene are among the most widely studied 
dietary antioxidants. Vitamin C is considered the most important water-soluble 
antioxidant in extracellular fluids. It is capable of neutralizing ROS in the aqueous 
phase before lipid peroxidation is initiated. Vitamin E, a major lipid-soluble 
antioxidant, is the most effective chain-breaking antioxidant within the cell membrane 
where it protects membrane fatty acids from lipid peroxidation. Vitamin C has been 
cited as being capable of regenerating vitamin E.21,22 
1.3.4. Phytonutrients 
 A number of other dietary antioxidant substances exist beyond the traditional 
vitamins discussed above. Many plant-derived substances, collectively termed 
“phytonutrients,” or “phytochemicals,” are becoming increasingly known for their 
antioxidant activity. Phenolic compounds such as flavonoids are ubiquitous within the 
plant kingdom: approximately 3,000 flavonoid substances have been described. In 
plants, flavonoids serve as protectors against a wide variety of environmental 
stresses while, in humans, flavonoids appear to function as “biological response 
modifiers.23,24 
1.3.5. Endogenous antioxidants  
In addition to dietary antioxidants, the body relies on several endogenous 
defense mechanisms to help protect against free radical-induced cell damage. The 
antioxidant enzymes – glutathione peroxidase, catalase, and superoxide dismutase 
(SOD) – metabolize oxidative toxic intermediates and require micronutrient cofactors 
such as selenium, iron, copper, zinc, and manganese for optimum catalytic 
activity.25,26 
1.3.6. Antioxidant system in our body 
 The body has developed several endogenous antioxidant systems to deal with 
the reactive oxygen species. 
 Non-enzymatic system 
This include both lipid soluble vitamins and water soluble vitamins  
E.g.: Lipid soluble vitamins-α- tocopherol (vitamin E), carotenes 
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       Water soluble vitamins-ascorbic acid. 
 Enzymatic systems 
E.g.: Super oxide dismutase, catalase, peroxidase.27,28 
Herbs are found out to be a source of various phytochemicals which possess 
antioxidant property. 
1.4. ADVANTAGES OF HERBAL MEDICATION 
 Herbal medicine exhibit fewer side effects and they are very much safe. Plants 
are gifts of natural to mankind for treating different types of diseases. Herbal 
medicines are cheaper and easily available. Also for certain diseases like hepatitis, 
herbs and herbal drugs are the only remedies. The traditional medicine is largely 
getting popularity over allopathic medicine because of their cost, availability and free 
from side effects.29 
The plant Alpinia calcarata has been traditionally used for various diseases. In 
present study rhizomes of the plant Alpinia calcarata have been used which 
traditionally indicated in the treatment of asthma.30 
1.5. HERBAL DRUGS USED IN ANTI – ASTHMATIC STUDY 
Table No.2: List of Herbal Drugs used in Anti – asthmatic study 
SL.
NO 
PLANT FAMILY PART EXTRACT MODEL AUTHORS 
1 Aerva lanta Amaranthaceae Aerial 
parts 
Ethanol 
1) 100 µg/mL 
in the isolated 
goat tracheal 
chain 
preparation 
model. 
2) 30 and 60 
mg/kg doses 
orally in 
clonidine-
Kumar D,  
Prasad DN,  
Parkash J,  
Bhatnaga.S. 
P, 
Kumar.D.
65
 
Introduction 
 
Page | 21 
induced 
catalepsy. 
3) Mast cell 
degranulation 
in mice 
possesses 
anti-asthmatic 
activity 
2 Ageratum 
conyzoides 
Asteraceae Leaves Hydro 
alcoholic 
1) Inhibiting 
clonidine 
induced 
catalepsy in 
mice 
 
 
Tote MV,  
Mahire NB, 
Jain AP,  
Bose S, 
Undale VR, 
Bhosale 
66
 
3 Asystasia 
gangetica 
Acanthaceae Leaves Evaluated 
hexane, 
ethyl 
acetate, 
and 
methanol 
extracts 
1)Anti-
asthmatic 
activity using 
guinea pig 
trachea, 
2) Rat 
stomach strip, 
3) Guinea pig 
ileal 
preparation, 
3) Egg 
albumin-
induced acute 
inflammation.  
 
Akah PA,  
Ezike AC, 
Nwafor SV,  
Okoli CO, 
Enwerem. 
NM
67
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4 Bacopa 
monnieri 
Scrophulariaceae Leaves Evaluated 
petroleum 
ether, 
chloroform, 
methanol 
and water 
extracts  
1)Mast cell 
stabilizing 
activity in rats. 
 
Samiulla DS,  
Prashanth.D 
, Amit A 
68
 
 
 
5 Cassia 
sophera 
Caesalpiniaceae Leaves Ethanol 1) Anti-
asthmatic 
activity in 
carrageenan 
induced paw 
edema, 
2) Histamine 
induced 
bronchoconstr
iction, 
3) Clonidine 
and 
haloperidol 
induced 
catalepsy, 
4) Milk 
induced 
leukocytosis, 
and 
eosinophilia, 
5)Passive paw 
anaphylaxis 
animal-
models. 
Nagore DH,  
Ghosh VK,  
Patil MJ.
69 
6 Casuarina 
equisetifolia 
Casuarinaceae Wood   
& Bark 
Methanol 
1)Antihistami-
nic activity by 
Aher AN,  
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inhibiting the 
histamine 
induced 
contraction of 
trachea (10-80 
mcg/mL), 
2) Clonidine 
induced 
catalepsy and 
mast cell 
degranulation 
at doses 100 
mg/kg. 
Pal SC,  
Pati UK,  
Yadav SK,  
 
Bhattacharya 
S.
70 
7 Clerodendrum 
Serratum 
Verbenaceae Roots Ethanol 
1)Anti- 
asthmatic 
activity using 
isolated goat 
tracheal chain 
preparation,  
2) Clonidine 
induced 
catalepsy, 
3) Milk 
induced 
leukocytosis 
and 
eosinophilia in 
mice. 
Bhujbal SS,  
Kewatkar 
SM, 
Kumar.D, 
Mudgade.SC 
, Patil MJ.
71 
 
8 Cnidium 
monnieri 
Umbelliferae Fruits Ethanol 
1) In passive 
cutaneous 
anaphylaxis in 
rats. 
Matsuda H, 
Tomohiro N, 
Yasuko,  
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Kubo M.
72 
9 Curculigo 
orchioides  
Amaryllidaceae Rhizome Alcoholic 
1) Induced 
mast cell 
degranulation 
and systemic 
anaphylaxis, 
 2) Inhibited 
histamine-
induced 
contraction in 
goat trachea, 
guinea pig 
ileum, 
3)Bronchocon
striction in 
guinea pigs,  
3)Egg albumin 
induced 
passive paw 
anaphylaxis in 
rats, 
4) Milk 
induced 
leukocytosis  
and 
eosinophilia, 
5) Clonidine 
induced 
catalepsy in 
mice. 
 
Venkatesh.P 
,Mukherjee.
PK, 
Satheesh 
Kumar N,  
Neelesh K 
Nema, 
 
Bandyopadh
yay A,  
Hiroyuki 
Fukui 
73
 
Pandit P,  
Singh A,  
Bafna AR,  
Kadam PV,  
Patil MJ 
74 
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10 Euphorbia 
hirta 
Euphorbiaceae Whole 
aerial 
part 
Ethanol 
1) Inhibited 
the passive 
cutaneous 
anaphylaxis 
and paw 
anaphylaxis 
reaction, 
2) Protection 
of mast cell 
from 
degranulation. 
Youssouf 
MS, 
Kaiser.P, 
Tahir M,  
Singh GD,  
Singh S, 
Sharma 
VK
75. 
11 Hemidesmus 
indicus 
Asclepiadaceae Roots Ethanol 
1) Isolated 
goat tracheal 
chain 
preparation, 
2) Passive 
paw 
anaphylaxis in 
rat, 
3) Clonidine-
induced 
catalepsy in 
mice. 
Bhujbal SS,  
Kumar D,  
Deoda RS,  
Deore TK, 
Patil MJ.
76 
12 Ficus 
bengalensis 
Moraceae Bark Ethyl 
acetate, 
ethanol and 
aqueous 
extracts. 
1)Antihistami-
nic activity by 
inhibiting 
clonidine 
induced 
catalepsy in 
mice. 
Taur DJ,  
Nirmal SA, 
Patil RY
77,78 
 
Introduction 
 
Page | 26 
1.5. PLANT PROFILE 
 Figure No.1: Alpinia calcarata – PLANT 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No.2: Rhizome. 
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1.5.1. PLANT DESCRIPTION 
Selected plant    : Alpinia calcarata 
1.5.1.1. Classification 
Kingdom           :        Plantae 
Division             :       Mangnoliphyta 
Class                  :       Liliopsida 
Order                 :       Zingiberales 
Family               :       Zingiberaceae 
Genus                :       Alpinia 
Species              :       Alpinia calcarata 
1.5.1.2. Synonyms 
Alpinia calcarata Rosk., Alpinia erecta Lodd. and Steud., Alpinia bracheata Rosk., 
Alpinia cerrnta Sims., Renealmia calcarata Haw., Globba eracta Retx., Languas 
calcarata Mem.31 
1.5.1.3. Selected Vernacular Names 
Sinhala- Heen aratta, Aratta 
English- Galanga, Small galanga 
Tamil- Amkolinji  
Sanskrit- Rasna32 
1.5.1.4. Distribution` 
It is native to India. Occurs in Southern Malay Peninsula and Sri Lanka. It is 
common in village gardens in Sri Lanka.33 
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1.5.1.5. Botanical description 
Alpinia calcarata is a rhizomatous perennial herb with a non-tuberous 
rootstock, stems slender, about 75 cm tall; leaves simple, alternate, 25 - 32 cm long 
and 2.5 - 5 cm broad, lanceolate, acuminate, long-pointed, glabrous on both surfaces 
and shining on the upper surface, scantily hairy along the margin, petioles sheathing; 
flowers pinkish white, irregular, bisexual, in pendunculate, terminal, dense flowered 
panicles 8.5 cm long, two flowers together at each node, one opening earlier than the 
other, each bearing a pair of bracteoles, the inner one smaller than the outer, 
bracteoles oblong, papery white, each flower about 4 cm long, pedicels short, hairy; 
sepals 3, fused into a campanulate tube l cm long, pubescent outside, glabrous 
inside, apices rounded; petals 3, fused at base but segments free tinged with pink, 
segments oblong-spathulate, pubescent outside, lateral narrow; staminodes 3, fused 
at base with the stamen into a tube adnate to corolla, two basal staminodes reduced 
to minute filaments, the larger one petaloid, 3 cm by 2.3 cm ovate, yellow with vinous 
red streaks, emarginated, apex frilled and darker, glabrous and shining on both 
surfaces; stamen, anther tubular, style passing through, filament flat, 1.5 cm long, 
anther 0.8 cm long, style 3.5 cm long, tinged pink, hairy towards the apex, stigma 
swollen; ovary inferior, 3 mm long, strongly pubescent, 3-locular with ovules in each 
loculus on a central axis capsules not seen.34, 35 
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Silvy Mathew et al., (2014)36 conducted a study on the antimicrobial activity 
of the plant Alpinia calcarata rhizome. The present study was designed to investigate 
the anti-microbial activity of four solvent extracts (Petroleum ether, Dichloromethane, 
Acetone and Methanol) of rhizome of Alpinia calcarata. The rhizome of this plant is 
an important antimicrobial agent and a digestive stimulant. The plant extracts showed 
considerable activity against ten tested strains viz., Pseudomonas aeroginosa, 
Escherichia coli, Enterobacter aerogens, Bacillus subtilis, Staphylococcus aureus, 
Streptococcus faecalis, Vibrio cholerae, Salmonella paratyphi, Klebsiella pneumoniae 
and Proteus vulgaris by using agar disc diffusion assay. This study reveals that 
Alpinia calcarata has antimicrobial activity against gram positive and gram negative 
bacteria.  
Arambewela L et al., (2004)37 conducted a study on the antinociceptive 
activities of aqueous and ethanolic extracts of Alpinia calcarata rhizomes in rats. 
Rhizomes of Alpinia calcarata (Zingiberaceae) possess several bio-activities and are 
used in traditional medicine of Sri Lanka. However, their antinociceptive activity has 
not been investigated so far. The aim of this study therefore, was to examine the 
antinociceptive activity of hot water extract (HWE) and hot ethanol extract (HEE) of 
Alpinia calcarata rhizomes using rats and three models of nociception (tail flick, hot 
plate and formalin tests). Different concentrations of HWE (100, 250, 500, 750,    
1000 mg/kg) and HEE (100, 250, 500, 750, 1000 mg/kg) were made and orally 
administrated to rats and the reaction times determined. The results showed that the 
extracts have marked dose-dependent antinociceptive activity, when evaluated in the 
hot plate and the formalin tests but not in the tail flick test. The antinociceptive effect 
was slightly higher in HEE than that of HWE. The antinociceptive effect was mediated 
via opioid mechanisms.   
Ramya Rajasekar et al., (2014)38 proposed a study on the antidiabetic activity 
of the Alpinia calcarata rhizomes. The study was to determine effect of              
Alpinia calcarata on glucose uptake in diabetic rats-an in vitro and in vivo model. 
Diabetes mellitus is a heterogeneous metabolic disorders characterized by 
abnormally high levels of blood glucose The main objective of the present work is to 
study the effect of Alpinia calcarata on glucose uptake in streptozotocin (STZ) 
induced diabetic rats. 
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The diabetes was induced by single dose of STZ (45 mg/kg) in citrate buffer, 
while the normal control group was given the vehicle (citrate buffer) only. After 
induction of diabetes, the diabetic animals were treated with ethanolic extract of 
Alpinia calcarata (200 mg/kg) and glibenclamide (2 mg/kg) for 30 days. Blood 
glucose estimation was performed every week of the study. At the end of study 
period, animals were sacrificed for biochemical studies.   
Streptozotocin induced diabetic rats shows the altered levels of various 
biochemical profiles. Those levels were brought back to near normal upon treatment 
with ethanolic extract of Alpinia calcarata and standard drug glibanclamide. No 
significant changes were observed on treatment with plant. 
Lakshmi Arambewela et al., (2011)39 conducted a study on the safety profile 
of the plant Alpinia calcarata rhizomes. The aim of the present study was to 
investigate whether Alpinia calcarata (Family: Zingiberaceae) rhizomes have any 
toxic effects in rats. Albino wistar rats were used as the experimental model and 
orally administered hot water extract (HWE) and hot ethanolic extract (HEE) of 
Alpinia calcarata rhizomes at a dose of 1500 mg/kg respectively for 42 consecutive 
days. Administration of the HWE or HEE to rats did not result in any chronic toxic 
effects as evident from their effects on (a) liver function (b) kidney function (c) 
hematological parameters such as red blood cell (RBC) count, white blood cell 
(WBC) count and haemoglobin (Hb) concentration (d) external morphology and wet 
weights of selected organs. Further, the HWE and the HEE did not appear to mediate 
any unacceptable effects on food and water intake, % weight gain, consistency of 
faeces and color of urine. In conclusion, the results of this study have revealed that 
the HWE and the HEE of Alpinia calcarata at the doses tested do not produce any 
serious toxic side effects in rats. 
Mizanur Rahman etal., (2012)40 conducted a study on the anti-inflammatory, 
analgesic and gc – ms (gas chromatographic and mass spectrometric) analysis of 
essential oil of Alpinia calcarata rhizome. In the present study, essential oil isolated 
from Alpinia calcarata was analyzed and also assessed for acute toxicity, anti-
inflammatory and analgesic activities in animals. The essential oil isolated from 
Alpinia calcarata was analyzed by using GC-MS on a combined GC-MS instrument. 
For evaluation of the anti-inflammatory property “carrageenan induced paw edema 
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model” served as acute model. “Acetic acid induced writhing response model” was 
used to assess analgesic activity in mice. The major components of essential oils 
isolated from Alpinia calcarata were Camphene (3.86%), Betamyrcene (4.39%), 
Eucalyptol (14.05%), Linalol (2.48%), Pyrazine (1.72%), L-camphor (7.90%) and 
Berneol (5.67%). Intraperitoneal injection of essential oil isolated from Alpinia 
calcarata significantly suppressedthe paw edema induced by carrageenan in two 
different dose levels studies namely 400 mg/kg and 380 mg/kg. Intraperitoneal 
injection of essential oil also significantly attenuated the acetic acid induced writhing 
response in three different dose levels studies namely 200 mg/kg, 400 mg/kg and  
600 mg/kg. These studies suggest that essential oil isolated from Alpinia calcarata 
might possess significant anti-inflammatory activity and analgesic effect and could be 
a potential source for treatment of different inflammatory diseases. 
Ratnasooriyaetal., (2006)41 conducted a study on the effect of aqueous 
extract of the plant Alpinia calcarata rhizomes on reproductive competence of male 
rats. This study examined the effects of rhizomes of Alpinia calcarata (Zingiberaceae) 
on male sexual competence and fertility, using a hot water extract (HWE) and rats. 
Different doses of HWE (150, 250 and 500 mg/kg) were orally administrated to male 
rats and their sexual behaviour was monitored 3 hours later using receptive females. 
Fertility was determined in a separate group (with the highest dose) using a 
noncompetitive copulation test. In the sexual behaviour study, the HWE impaired the 
number of rats ejaculating and markedly prolonged the latency for ejaculation. 
Further, the number of rats mounting and intromitting, and the latencies for mounting 
and intromission were inhibited. Collectively, these observations indicate a strong 
aphrodisiac action. The other parameters remained unchanged indicating non-
impairment in libido, sexual arousability, sexual vigour and sexual performance or 
penile erectile ability. However, a slight impairment was evident in sexual motivation 
(with the highest dose) in a partner preference test. In the fertility test, HWE induced 
profound oligozoospermia but fertility was uninhibited. The highest dose of HWE also 
elevated the serum testosterone level and the number of spontaneous penile 
erections rapidly and markedly. Further, the HWE was nontoxic. It is concluded that 
Alpinia calcarata rhizomes possess a strong and safe oral aphrodisiac activity. 
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3.1. AIM & OBJECTIVES 
In recent year there has been tremendous increase in demand for herbal drugs 
because of its safety, efficacy and better therapeutic results. Due to its economic 
pricing as compared to synthetic or allopathic drugs, which have several therapeutic 
compilations. 
Alpinia calcarata is also considered to be therapeutically important in traditional 
system of medicine. 
Aim of the study to evaluate the anti-asthmatic, antioxidant and anti-inflammatory 
activities of ethanolic extract of Alpinia calcarata rhizome. 
The objective study includes 
 To study the anti-asthmatic effect of ethanolic extract of Alpinia calcarata 
rhizomes. 
 To study the in vitro antioxidant activity of the ethanolic extract of Alpinia calcarata 
rhizomes. 
 To study the in vitro anti-inflammatory activity of the ethanolic extract of  
Alpinia calcarata rhizomes. 
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4.1. PLAN OF WORK 
1. Collection and authentification of plant material (rhizomes of              
Alpinia calcarata 
2. Extraction of the plant material (Rhizomes of the plant Alpinia calcarata). 
3. Conduction of the preliminary phytochemical screening and finding out the 
phytoconstituents present in the ethanolic extract of Alpinia calcarata 
rhizomes. 
4. Performing of acute toxicity studies of ethanolic extract of Alpinia calcarata 
rhizomes (OECD 423). 
5. Evaluation of the anti-asthmatic effect of Alpinia calcarata rhizomes 
 In vivo methods  
1. Histamine aerosol induced bronchoconstriction in guinea pigs. 
2. Milk induced leukocytosis and eosinophil count 
 Ex vivo methods 
      1. Isolated guinea pig tracheal preparation.                           
6. Evaluation of the antioxidant study of Alpinia calcarata rhizomes 
 In vitro methods 
1. Hydrogen peroxide scavenging assay 
2. Reducing power assay 
7. Evaluation of the anti-inflammatory study of Alpinia calcarata rhizomes 
 In vitro methods 
1. Protein denaturation method 
2. The rabbit red blood cell (RRBC) membrane stabilization 
method. 
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5.1. MATERIALS 
5.1.1. Plant selected 
 In the present study, Alpinia calcarata was selected because of its traditional 
uses. The part used was rhizomes. 
5.1.2. Chemicals and reagents used 
 Carboxy methyl cellulose (Spectrum reagents and chemicals pvt. Ltd.) 
 Ascorbic acid (Spectrum reagents and chemicals pvt. Ltd.) 
 Histamine (NICE chemicals pvt.Ltd.) 
 Hydrogen peroxide (Spectrum reagents and chemicals pvt. Ltd.) 
 Glacial acetic acid (Ozone international, Mumbai) 
 Trichloro acetic acid (NICE chemicals pvt. Ltd.) 
 Diclofenac sodium (Rajesh chemicals, Mumbai) 
5.1.3. Drugs used 
 Chlorpheniramine maleate (Abbott Laboratories pvt. Ltd.) 
 Dexamethasone (Zydusbiogem, cadila health care Ltd.) 
5.1.4. Instruments used for the study 
 UV- Visible spectrophotometer- Jasco international 
 Incubator- Rotek Instruments, B&C Industries, W. Vengola. 
 Centrifuge- Rotek Instruments, B&C Industries, W. Vengola. 
 Histamine chamber- Orchid Scientific Innovations India pvt. Ltd 
5.1.5. Animals 
 Swiss albino mice (25-40 gm) and Guinea pig (400-600 gm) were used to 
carry out the activities. The animals had free access to standard commercial diet and 
water. Animals were housed in cages under standard conditions i.e., 12:12 hour light 
or dark cycle at 25±20 C. The experiments were carried out as per the guideline of 
CPCSEA, New Delhi, India. 
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5.2. METHODS 
5.2.1. Collection and authentication of Alpinia calcarata 
The dried rhizomes of the Alpinia calcarata were collected. The rhizomes were 
cleaned and shade dried and milled into coarse powder by a mechanical grinder. 
5.2.2. Preparation of plant extract 
 The powdered rhizomes were extracted using ethanol by soxhlet extractor. In 
this process the powdered drug is placed into the extractor with ethanol as solvent. 
After extraction the extract was concentrated by evaporation then it was kept in a 
refrigerator for further use.42, 43 
5.2.3. Preliminary phytochemical screening 
The ethanolic extract of Alpinia calcarata rhizomes were subjected for the 
following chemical tests for the identification of various active constituents.44, 45 
5.2.3.1. Detection of carbohydrates: - 
 Molish test (General test) 
To 2-3 ml of aqueous extract, add few drops of α-naphthol solution 
in alcohol, shake and add conc. H2SO4 from a test tube. Violet ring 
is formed at the junction of two liquids. 
 Test for reducing sugar 
(a)Fehling’s test 
Mix 1 ml of fehling’s A and 1 ml of fehling’s B solution Boil for 1 min. 
Add equal volume of test solution. Heat in boiling water bath for5-10 
min. First yellow, then brick red precipitate observed. 
(b) Benedict’s test 
Mix equal volume of benedict’s reagent and test solution in a test 
tube. Heat in boiling water bath for 5 min. Solution appears green, 
yellow or red depending on amount of reducing sugar present in test 
solution. 
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5.2.3.2. Detection of protein: - 
 Biuret test (General test) 
3 ml of test solution add 4% NaOH and few drops of 1% CUSO4 
solution. Violet or pink color appear. 
 Million’s test (for proteins) 
Mix 2 ml of extract with million’s reagent. white precipitate formed. 
warm precipitate turns brick red or the precipitate dissolves giving red 
colored solution. 
5.2.3.3. Detection of proteins and amino acids: - 
About 100 mg of extract was dissolved in 10 ml of distilled water and filtered through 
Whatman No.1 filter paper and the filtrate was subjected to tests for proteins and 
amino acids. 
 Biuret test (General test) 
3ml of test solution add 4% NaOH and few drops of 1% CUSO4 
solution. Violet or pink color appear. 
 Million’s test (for proteins) 
Mix 2 ml of extract with millions reagent. White precipitate formed. 
Warm precipitate turns brick red or the precipitate dissolves giving red 
colored solution 
 Ninhydrin test (for amino acid) 
About 2 drops of ninhydrin solution were added to 2 ml of test solution. 
Purple or bluish color appears 
5.2.3.4. Detection for Fats and oils: - 
 Solubility test  
Oils are soluble ether, benzene, chloroform but insoluble in 90% 
ethanol and in water. Hence filter paper get permanently stained with 
oils 
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5.2.3.5. Detection of steroid: - 
 Salkowski reaction 
To 2 ml of extract, add 2 ml chloroform and 2 ml con H2SO4 shake well. 
Chloroform layer appear red and acid layer shows greenish yellow 
fluorescence. 
 Liebermann – burchard reaction 
Mix 2 ml extract with chloroform. Add 1-2 ml of acetic anhydride and     
2 drops of con H2SO4 from the side of test tube. First red, then blue 
finally green color appear. 
5.2.3.6. Detection of glycoside: - 
1) Cardiac glycoside 
 Legal ‘s test (for cardiac glycoside) 
To aqueous or alcoholic extract add 1 ml pyridine and 1 ml sodium 
nitroprusside. pink to red color appears. 
 Test for reducing sugar (for cardiac glycoside) 
To 2 ml extract add glacial acetic acid one drop 5% Fecl3 and            
con H2SO4. Reddish brown color appears at junction of two liquid layer 
and upper layer appears bluish green. 
2) Anthraquinone glycoside 
 Bontragers test  
To 3 ml extract, dil. H2SO4 was added, boiled and filtered. To cold 
filtrate, equal volume of benzene or chloroform was added and shaken 
well. The organic solvent was separated and ammonia was added. The 
ammonical layer turns pink to red. 
3) Saponin glycoside 
 Foam test  
Shake the drug extract or dry powder vigorously with water. Persistant 
form observed. 
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 Heamolytic test  
Add drug extract or dry powder to one drop of blood placed on glass 
slide. Heamolytic zone appears 
4) Cyanogenic glycoside 
 Grignard reaction or sodium picrate test 
Soak a filter paper strip first in 10% picric acid, Then in 10%        
sodium carbonate, dry. In conical flask place moistened   powdered 
drug. Cork it, place the above filter paper strip in the slit in cork. Filter 
paper turn brick red or maroon.  
5) Coumarin glycoside 
 Coumarin glycoside have aromatic odour 
 Alcoholic extract when made alkaline, shows blue or green 
fluorescence 
5.2.3.7. Detection for flavonoids 
 Shinoda test 
To dry powder or extract, add 5ml 95% ethanol, few drops con. Hcl and 
0.5 g Magnesium turnings. Pink color observed. 
 To small quantity of residue, add lead acetate solution. Yellow color 
precipitate is formed. 
 Addition of increasing amount of NaOH to residue shows yellow 
coloration, which decolorizes after addition of acid. 
5.2.3.8. Detection of alkaloid 
 Aqueous alcoholic and chloroform extract was evaporated separately. To 
residue dilute Hcl was added. Shaken well and filtered. With the filtrate the following 
test was performed. 
 Dragondorff ‘s test 
To 2-3 ml. Filtrate, add few drops of dragondorff‘s reagent. Orange 
brown precipitate  
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 Mayers test 
To 2-3 ml of filtrate with few drops of mayer’s reagent gives precipitate 
 Hager’s test 
2-3 ml filtrate with hager’s reagent gives yellow precipitate 
 Wagner’s test 
2-3 ml of filtrate with wagner’s reagent gives reddish brown precipitate 
5.3. ACUTE TOXICITY STUDIES 
 Acute toxicity of Alpinia calcarata was done as per OECD guidelines 423. The 
substance was administered in a single dose by gavage using specially designed 
mice oral tube. Animals were fasted prior to dosing with food but not water withheld 
overnight. Following the period of fasting, the animals were weighed and the test 
substance was orally at a dose of 5, 50, 300 and 2000 mg/kg. The animals are 
observed continuously for first three hours, four any toxic manifestations like 
increased motor activity, salivation, acute convulsion, coma and death. Changes in 
the animal behavior should be noted before and after administration for 24hours. 
Treated animals are to be further observed for 14 days. If the extract does not 
produce mortality at the highest dose, then the 1/10th or 1/20th of the dose was 
selected for experiment.46, 47 
5.4. EVALUATION OF ANTI ASTHMATIC ACTIVITY 
5.4.1. In vivo anti-asthmatic activity 
5.4.1.1. Histamine aerosol induced bronchoconstriction in guinea pigs 
Histamine was dissolved in distilled water to prepare 0.2% w/v solution. 
Experimentally bronchial asthma was induced in guinea pigs by exposing histamine 
aerosol by a nebulizer in an aerosol chamber. The required time for appearance of 
preconvulsive dyspnoea produced by the histamine was noted for each animal. Each 
animal was placed in the histamine chamber and exposed to 0.2% histamine aerosol. 
The preconvulsion time (PCT), i.e. the time of aerosol exposure to the start of 
dyspnoea leading to the appearance of convulsion, was noted. As quickly as the 
preconvulsion dyspnoea (PCD) was recorded, the animals were removed from the 
chamber and positioned in fresh air for recover. This time for preconvulsive dyspnoea 
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was recorded as basal value. Guinea pigs were then allowed to recover from 
dyspnoea for 2 days. After that, the animals were allotted to four different groups of 
4-5 animals per group. Animals in group 1 served as control and received carboxy 
methyl cellulose. The animals of group 2 and 3 were given, by oral intubation, 100 
and 200 mg/kg of the plant extract, respectively, while group 4 received the standard 
drug - Chlorpheniramine maleate, intraperitoneally. After receiving the drugs, all the 
animals were again exposed to histamine aerosol in the chamber, one hour, four 
hours and 24 hours, to determine pre convulsive time (PCT).48, 49, 50 
Percentage protection was calculated using the formula. 
Percentage protection = 
𝐸௧௔−𝐸௧௕𝐸௧௔ × ͳͲͲ 
Where Eta is the preconvulsion time after administration of drug and Etb is the 
preconvulsion time before administration of drug. 
5.4.1.2. Milk induced leukocytosis and eosinophilia    
Mice were divided into 4 groups with six in each group. Blood samples were 
collected from retro-orbital plexus. Group 1 served as control and received carboxy 
methyl cellulose solution, groups 2-3 received plant extract at (100-200 mg/kg) group 
4 received dexamethasone at 50 mg/kg i.p. All the groups injected boiled and cooled 
milk (4 ml/kg, s.c.) 30 min after treatments. Total leukocyte and eosinophile count 
was done in each group before administration of test compound and 24 hours after 
milk injection. Difference in total leukocytes and eosinophile count before and after 
24-hour drug administration was calculated.51, 52 
5.4.2. Ex vivo anti-asthmatic activity 
5.4.2.1. Isolated guinea pig tracheal preparation  
Isolated guinea pig tracheal tissue was obtained by, Animals were sacrificed 
by cervical dislocation and carotid bleeding. The trachea was dissected out and 
transferred into a dish containing Krebs solution and cut crosswise between the 
section of the cartilage of the trachea and continuously ventilated and maintained at 
37 + 0. 5°C.The adjourned trachea was allowed to make steady for at least             
40 minutes. On equilibrium, the bath was supplied with Krebs solution for every       
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15 minutes Dose response curve of histamine (10 µg/ml) in plane Krebs solution and 
in 1 mg/ml of plant extract act in Krebs solution was taken. Percentage of maximum 
contractile response on ordinate and concentration of histamine on abscissa was 
plotted to record dose response curve of histamine, in absence and presence of plant 
extract.48, 54 
5.5. IN VITRO ANTIOXIDANT ACTIVITY 
5.5.1. Hydrogen peroxide scavenging 
Hydrogen peroxide solution (20 Mm) was prepared with standard phosphate 
buffer (pH 7.4). Extract samples (25, 50, 100, 200 and 400 μg/ml) in distilled water 
were added to hydrogen peroxide solution (0.6 ml). Absorbance of hydrogen 
peroxide at 230 nm was determined after 10 minutes against a blank solution 
containing phosphate buffer without hydrogen peroxide. Ascorbic acid was used as 
the reference standard. The percentage scavenging of hydrogen peroxide of plant 
extract was calculated using the formula.55 
% Scavenged = 
𝐴௖−𝐴௦𝐴௖ × ͳͲͲ 
Where, Ac = Absorbance of control 
As = Absorbance of sample 
The experiments were performed in triplicates, and the results were expressed as 
Mean± S.E.M 
5.5.2. Reducing power assay 
The reducing power of the extract was determined by the method. 1 ml of the 
extract solution (25, 50, 100, 200 and 400 μg/ml) was mixed with 2.5 ml phosphate 
buffer (0.2 M, Ph 6.6) and 2.5 ml of potassium ferricyanide ([K2 Fe (CN)6] (10g/l)), 
then the mixture was incubated at 500 C for 20 minutes. A portion (2.5ml) of 
trichloroacetic acid (TCA) (15%) was added to the mixture, which was then 
centrifuged at 3000 rpm for 10 minutes. Finally, 2.5 ml of the supernatant solution 
was mixed with 2.5 ml of distilled water and 0.5ml ferric chloride (FeCl3. 0.1%) and 
absorbance was measured at 700 nm in UV- visible spectrophotometer. The 
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experiments were performed in triplicate. Increased absorbance of reaction mixture 
indicates stronger reducing power.56, 57 
5.6. IN VITRO ANTI-INFLAMMATORY ACTIVITY 
5.6.1. Protein denaturation  
 A solution of 0.2% of bovine serum albumin (BSA) was prepared in tris buffer 
saline and pH was adjusted to 6.8 using glacial acetic acid. Test drug of different 
concentration (25, 50, 100, 200 and 400 μg/ml) was prepared using ethanol as 
solvent. 50 μl of each test drug was transformed to test tubes using micropipette.      
5 ml of 0.2% w/v of BSA was added to the test tubes. The control consists of 5 ml of 
0.2% w/v of BSA solution and 5μl alcohol. The test tubes were heated at 720 C for    
5 min and then cooled for 10 min. The absorbance of these solution was determined 
using UV–visible spectrophotometer at 660nm. Diclofenac sodium was used as 
standard and treated similarly for determination of absorbance. The percentage 
inhibition of protein denaturation was calculated using the following formula.58, 59 
Percentage of inhibition of denaturation = 
𝐴௕௦௢௥௕௔௡௖௘ ௢௙ ௖௢௡௧௥௢௟−𝐴௕௦௢௥௕௔௡௖௘ ௢௙ ௘௫௧௥௔௖௧𝐴௕௦௢௥௕௔௡௖௘ ௢௙ ௖௢௡௧௥௢௟ × ͳͲͲ 
5.6.2. The rabbit red blood cell membrane stabilization method 
o Preparation of red blood cell suspension (RBCs suspension) 
 The fresh whole rabbit blood (5 ml) was collected from marginal ear vein to 
syringes containing sodium citrate to prevent clotting. The tubes were centrifuged at 
3000 rpm for 10 minutes and were washed 3 times with equal volume of normal 
saline. The volume of the blood was measured and reconstituted as 10% v/v 
suspension with normal saline. 
o Membrane stabilization test by hypotonicity induced haemolysis 
 The reaction mixture consists of 1 ml of test sample of different concentration 
(25, 50, 100, 200 and 400 μg/ml) in normal saline and 0.5 ml of 10% RBC 
suspension, 1 ml of 0.2 M phosphate buffer, 1 ml hypo saline were incubated at     
370C for 30 minutes and centrifuged at 3000 rpm for 20 minutes and the 
haemoglobin content of the supernatant solution was estimated 
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spectrophotometrically at 560 nm. Diclofenac sodium was used as standard and a 
control was prepared without extract. The percentage of RBC haemolysis and 
membrane stabilization or protection was calculated using the following formula.60, 61 
% Haemolysis =
𝑂௣௧𝑖௖௔௟ ௗ௘௡௦𝑖௧௬ ௢௙ ௧௘௦௧ ௦௔௠௣௟௘𝑂௣௧𝑖௖௔௟ ௗ௘௡௦𝑖௧௬ ௢௙ ௖௢௡௧௥௢௟ × ͳͲͲ 
% Protection =100 - % Haemolysis 
5.7. STATISTICAL ANALYSIS 
 The statistical analysis was carried out by using one-way analysis of variance 
(ANOVA) followed by Dunnett's multiple comparison test. The results are expressed 
as Mean±S.E.M., n=6 
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6.1. COLLECTION & AUTHENTIFICATION OF ALPINIA CALCARATA 
RHIZOME 
 The rhizomes of Alpinia calcarata were collected and authentified. 
6.2. EXTRACTION OF PLANT MATERIAL 
 Alpinia calcarata rhizomes were collected, washed and shade dried. Dried 
rhizomes were crinkled in to powdered form, weighed out. Extraction of coarse 
powder was done by soxhlet extraction with ethanol. The percentage yield of the 
product was found to be 17 % w/w. 
6.3. PRELIMINARY PHYTOCHEMICAL SCREENING OF ETHANOLIC 
EXTRACT OF ALPINIA CALCARATA RHIZOMES (EEAC) 
The phytochemical screening of the ethanolic extract of the Alpinia calcarata 
rhizomes indicate the presence of carbohydrate, cardiac glycoside, protein, alkaloids, 
steroids, flavonoids, tannins and phenolic compounds. 
Table No.3: Preliminary phytochemical analysis 
Sl. No: Constituents Presence/absence 
1 Carbohydrate  + 
2 Proteins  + 
3 Amino acids _ 
4 Fats and oils _ 
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5 Steroids  + 
6 Cardiac glycosides + 
7 Anthraquinone glycoside _ 
8 Saponin glycosides _ 
9 Cyanogenic glycosides _ 
10 Coumarin glycosides _ 
11 Flavonoids + 
12 Alkaloids _ 
13 Tannins + 
14 Phenol  + 
(+: presence, -: absence) 
6.4. ACUTE TOXICITY STUDIES 
 Acute toxicity studies of ethanolic extract of Alpinia calcarata rhizomes was 
performed according to OECD guidelines 423 using swiss albino mice. At the dose 
2000 mg/kg, the ethanolic extract were neither produced mortality nor the sign of 
morbidity. Hence the dose 100 mg/kg (1/20th of 2000 mg/kg) and 200mg/kg (1/10th 
dose of 2000 mg/kg). 
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6.5. EVALUATION OF ANTI ASTHMATIC ACTIVITY 
6.5.1. In vivo anti asthmatic activity 
6.5.1.1. Histamine aerosol induced bronchoconstriction in guinea pigs 
Histamine was dissolved in distilled water to prepare 0.2% w/v solution. 
Experimentally bronchial asthma was induced in guinea pigs by exposing histamine 
aerosol by a nebulizer in an aerosol chamber. The required time for appearance of 
pre convulsive dyspnoea produced by the histamine was noted for each animal. 
Each animal was placed in the histamine chamber and exposed to 0.2% histamine 
aerosol. The preconvulsion time (PCT), i.e. the time of aerosol exposure to the start 
of dyspnoea leading to the appearance of convulsion, was noted. As quickly as the 
preconvulsion dyspnoea (PCD) was recorded, the animals were removed from the 
chamber and positioned in fresh air for recover. This time for preconvulsive dyspnoea 
was recorded as basal value. Guinea pigs were then allowed to recover from 
dyspnoea for 2 days. After that, the animals were allotted to four different groups of 
4-5 animals per group. Animals in group 1 served as control and received carboxy 
methyl cellulose. The animals of group 2 and 3 were given, by oral intubation, 100 
and 200 mg/kg of the plant extract, respectively, while group 4 received the standard 
drug - Chlorpheniramine maleate, intraperitoneally. After receiving the drugs, all the 
animals were again exposed to histamine aerosol in the chamber, one hour, four 
hours and 24 hours, to determine pre convulsive time (PCT).48, 49, 50 
Percentage protection was calculated using the formula. 
Percentage protection = 
𝐸𝑡௔−𝐸𝑡௕𝐸𝑡௔ × ͳͲͲ 
Where Eta is the preconvulsion time after administration of drug and Etb is the 
preconvulsion time before administration of drug. 
                  The present study deals with the screening of anti-asthmatic 
activity of ethanolic extract of Alpinia calcarata rhizomes by histamine induced 
bronchoconstriction in guinea pigs. The ethanolic extract of the plant expressively 
extended the latent period of convulsion followed by exposing to histamine at the 
dose 200 mg/kg at time 4 hours as compared to standard drug. The % protection was 
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calculated from the latent period of convulsion. The maximum % protection of 
ethanolic extract of the plant was calculated as 60.79% at 200 mg/kg.  
The standard drug used was chlorpheniramine maleate which showed 
significant % protection at time 1 hour and 4 hours. The plant extract at 100 mg/kg 
showed 43.2% protection at time 1 hour and the 100 mg/kg plant extract also showed 
40.2% protection at time 24 hour and also showed 57.2% protection at time 4 hour. 
The control (Carboxy methyl cellulose) produced 10.9 % protection at time 1 hour 
and 12.3% protection at time 4 hour and 11.4% protection at time 24 hour. The plant 
extract at 200 mg/kg showed 48% at time 1 hour and 60.79% at time 4 hour and 
44.3% at time 4 hour and 44.3% at 24 hours. The standard drug chlorpheniramine 
maleate possess 69.76% protection at time 1 hour and 78.3% at time 4 hour and 
50.1% at time 24 hour. 
The results of histamine aerosol induced bronchoconstriction in guinea pigs 
was shown in the table number 4 and figure number 3. 
Table No.4: Histamine aerosol induced bronchoconstriction in guinea pigs 
Group Latent period of convulsion 
Before 1 hour 4 hour 24 hour 
Control 16.3±2.23 18.36±0.183 18.63±0.186 18.4±0.12 
Alpinia calcarata 
Ethanolic extract 
(100 mg/kg) 
16.71±1.31 29.65±.28 39.38±0.05* 28.2±0.23 
Alpinia calcarata 
Ethanolic extract 
(200 mg/kg) 
15.71±0.77 30.5±3.08 40.36±1.04* 28.4±.35 
Standard (CPM) 
(1 mg/kg) 
18.46±0.89 60.25±0.03* 68.26±1.01** 36.5±0.55 
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Values are Mean± S.E.M., where n=6 in each group, P< 0.05 *, P< 0.01 ** (significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
Figure No.3: Effect of ethanolic extract of Alpinia calcarata rhizomes against 
histamine induced bronchoconstriction in guinea pigs 
 
Table No.5: % Protection of the plant Alpinia calcarata rhizomes against histamine 
induced bronchoconstriction in guinea pig 
Group 
%protection 
1 hour 4 hour 24 hour 
Control (carboxy methyl cellulose) 10.9 12.3 11.4 
Alpinia calcarata 
ethanolic extract (100 mg/kg) 
43.2 57.2 40.2 
Alpinia calcarata 
ethanolic extract (200 mg/kg) 
48 60.79 44.3 
Standard(CPM) 69.76 78.3 50.1 
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Figure No.4: % Protection of the plant Alpinia calcarata rhizomes against histamine 
induced bronchoconstriction in guinea pigs 
 
6.5.1.2. Milk induced leukocytosis and eosinophilia 
6.5.1.2.1. Milk induced leukocytosis 
 In the milk induced leukocytes the maximum increase in difference of 
leukocytes count was observed in control group (4100 ± 9) 24 hour after 
administration of milk. Groups of mice pretreated with ethanolic extract (200 mg/kg) 
showed significant activity. The ethanolic extract of plant Alpinia calcarata             
(200 mg/kg) showed decrease in number of leukocytes (1280 ± 12) as compared to 
control. The standard drug possesses significant activity (600±10) and the plant 
extract (100 mg/kg) showed less significant activity as compared to control. 
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Table No.6: Effect of ethanolic extract of Alpinia calcarata rhizomes on milk induced 
leukocytosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are Mean± S.E.M., where n=6 in each group, P< 0.05 *, P< 0.01 ** (significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
Groups 
Difference in no of leukocytes 
before and after 
treatment(Cu.mm) 
Control 
(Carboxy methyl cellulose) 
4100±9 
Alpinia calcarata 
ethanolic extract (100 mg/kg) 
2580±8* 
Alpinia calcarata 
ethanolic extract (200 mg/kg) 
1280±12** 
Standard (Dexamethasone             
(50 mg/kg)) 
600±10** 
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Figure No.5: Effect of Alpinia calcarata rhizomes on milk induced leukocytosis 
 
6.5.1.2.2. Milk induced eosinophilia 
In this study difference in number of eosinophilic count before and after 
treatment was studied. In control group there was maximum increase in difference in 
number of eosinophilic count (118± 1.414) was observed. The ethanolic extract of 
Alpinia calcarata (200 mg/kg) showed significant activity by less difference in number 
of eosinophilic count (53 ±1.434). The standard drug also exhibited significant activity 
by less difference in number of eosinophilic count (38 ±1.13). The ethanolic extract of 
plant (100 mg/kg) showed less significant activity.  
The results were expressed in the table number 7and figure number 6. 
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Table No.7: Effect of ethanolic extract of Alpinia calcarata rhizomes on milk induced 
eosinophilia 
 
Values are Mean± SEM, where n=6 in each group, P< 0.05 *, P< 0.01 ** (significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
Groups 
Difference in no of eosinophilic count 
before and after treatment(Cu.mm) 
Control 
(Carboxy methyl cellulose) 
118±1.414 
Alpinia calcarata 
ethanolic extract (100 mg/kg) 
82±1.2* 
Alpinia calcarata 
ethanolic extract (200 mg/kg) 
53±1.434** 
Standard 
(Dexamethasone (50 mg/kg)) 
38±1.13** 
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Figure No.6: Effect of Alpinia calcarata rhizomes on milk induced eosinophilic count 
 
 
6.5.2. Ex vivo anti-asthmatic study 
6.5.2.1. Isolated guinea pig tracheal preparation 
Histamine (10 µg/ml) produced dose dependent contraction of guinea pig 
tracheal preparation. Pretreatment with the ethanolic extract of Alpinia calcarata 
rhizome (1mg/ml) significantly inhibited the contractile effect of histamine. 
Concentration Response Curve of guinea pig tracheal preparation before and 
after administration of plant extract are shown below. 
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Figure No.7: Concentration Response Curve of Histamine using Guinea pig tracheal 
preparation (In Absence of Plant Extract). 
 
Figure No.8: Concentration Response Curve of Histamine using Guinea pig tracheal 
preparation (In Presence of Plant Extract). 
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The results were expressed in table number 8 and the effect of Alpinia calcarata 
rhizomes on histamine induced contraction on isolated guinea pig tracheal is shown 
in figure number 9 
Table No.8: Effect of ethanolic extract of Alpinia calcarata rhizomes on histamine 
induced contraction on isolated guinea pig tracheal preparation 
Sl 
no Dose of 
histamine 
(10µg/ml) in ml 
Control 
(Histamine 10 
µg/ml) 
% maximum 
contraction 
                        Test 
Histamine(10µg/ml)+EEAC(1mg/ml) 
% maximum contraction 
1 0.1 38.46 ± 1.58 30.76 ± 1.32** 
2 0.2 53.48 ± 4.23 46.15 ± 2.91** 
3 0.4 61.5 ± 3.89 53.48 ± 3.31** 
4 0.8 73.07 ± 2.32 65.3 ± 1.76** 
5 1.6 84.6 ± 2.13 69.2 ± 1.09** 
6 3.2 100 ± 1.07 76.92 ± 2.11* 
Values are Mean± S.E.M., where n=6 in each group, P< 0.05 *, P< 0.01 ** (significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
Figure No.9: Effect of ethanolic extract of Alpinia calcarata rhizomes on histamine 
induced contraction on isolated guinea pig tracheal preparation  
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6.6. IN VITRO ANTIOXIDANT ACTIVITY 
6.6.1. Hydrogen peroxide scavenging  
 The hydrogen peroxide scavenging activity of ethanolic extract of             
Alpinia calcarata rhizomes was determined. The percentage hydrogen peroxide 
scavenging ability of the test extract increased in a dose dependent manner and the 
reference standard, ascorbic acid (100 µg/ml) exhibited 60.23% hydrogen peroxide 
scavenging activity. The maximum hydrogen peroxide scavenging activity shown by 
ethanolic extract of Alpinia calcarata rhizomes was found to be 53.3 % at 400 µg/ml. 
The hydrogen peroxide scavenging effect of ethanolic extract was shown in 
table number 9. 
Table No.9: Hydrogen peroxide scavenging activity of ethanolic extract of         
Alpinia calcarata rhizomes 
Sl 
no 
Concentration(µg/ml) Absorbance [A] % inhibition 
1 25 0.632±0.0005 17.16 
2 50 0.539±0.0052 29.5 
3 100 0.474±0.0056 38.04 
4 200 0.414±0.0005 46 
5 400 0.357±0.0032 53.3 
6 Ascorbic acid (100 µg/ml) 0.256±0.056 60.23 
 
(Values are Mean±S.E.M., where n=6) in each group, P< 0.05 *, P< 0.01 **(significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
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Figure No.10: Hydrogen peroxide scavenging activity of ethanolic extract of            
Alpinia calcarata rhizome. 
 
6.6.2. Reducing power assay 
Increase in absorbance of the extract indicates the reducing power of the test 
sample. Reducing power of ethanolic extract of Alpinia calcarata rhizomes increased 
with increasing concentration. Results are expressed below 
Table No.10: Reducing power activity of ethanolic extract of Alpinia calcarata 
rhizomes 
Sl 
no 
Concentration (µg/ml) Absorbance [A] 
1 25 0.782±0.32 
2 50 0.891±0.21 
3 100 1.3±0.35 
4 200 1.4±0.42 
5 400 1.56±0.82 
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(Values are Mean±S.E.M., where n=6) in each group, P< 0.05 *, P< 0.01 ** 
(significant) compared with control. Statistical analysis was done by one-way analysis 
of variance (ANOVA) followed by Dunnett’s multiple comparison test. 
Figure No.11: Reducing power assay of ethanolic extract of Alpinia calcarata 
rhizomes 
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Table No.11: Effect of ethanolic extract of Alpinia calcarata on protein denaturation 
Sl 
no 
Concentration (µg/ml) Absorbance [A] % inhibition 
1 25 1.28±0.05 14 
2 50 0.578±0.03 61.6 
3 100 0.382±0.002 74.63 
4 200 0.189±0.01 87.4 
5 400 0.172±0.002 88.57 
6 Diclofenac sodium (100µg/ml) 0.165±0.005 89.43 
 
(Values are Mean±S.E.M., where n=6) in each group, P< 0.05 *, P< 0.01 ** 
(significant) compared with control. Statistical analysis was done by one-way analysis 
of variance (ANOVA) followed by Dunnett’s multiple comparison test. 
Figure No 12: Effect of ethanolic extract of Alpinia calcarata on protein denaturation. 
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6.7.2. Rabbit red blood cell membrane stabilization method 
 The ethanolic extract of Alpinia calcarata rhizome had shown significant 
inhibition of haemolysis or the active RBC membrane stabilization comparing to 
diclofenac sodium the reference standard. The maximum percentage protection 
shown by test extract was 69.82% at 400 µg/ml and minimum percentage protection 
was found to be 41.4 at 25 µg/ml. The reference standard diclofenac sodium 
possesses 66.75% at concentration 100 µg/ml. 
Table No.12: Effect of ethanolic extract of Alpinia calcarata rhizomes on hypo tonicity 
induced RBC membrane stabilization. 
Sl 
no 
Concentration 
(μg/ml) 
Absorbance[A]   % Protection % Haemolysis 
1 25 0.61±0.03 41.4 58.6 
2 50 0.58±0.002 44.3 55.7 
3 100 0.382±0.004 63.3 36.7 
4 200 0.36±0.009 65.3 34.7 
5 400 0.32±0.007 69.82 30.18 
6 Diclofenac sodium  
(100 μg/ml) 
0.34±0.008 66.75 33.25 
 
(Values are Mean±S.E.M., where n=6) in each group, P< 0.05 *, P< 0.01 **(significant) 
compared with control. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s multiple comparison test. 
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Figure No.13: Effect of ethanolic extract of Alpinia calcarata rhizomes on               
hypo tonicity induced RBC membrane stabilization 
 
6.8. DISCUSSION 
6.8.1. Preliminary phytochemical screening of ethanolic extract of  
Alpinia calcarata rhizome. 
The ethanolic extract of Alpinia calcarata rhizomes were subjected to phytochemical 
screening. The result indicated that, rhizome extract shows the presence of 
carbohydrate, proteins, cardiac glycosides, flavonoid, tannins and phenol. The 
knowledge of chemical constituents of plant is desirable because such information 
will be valuable for synthesis of complex chemical substances and to screen for 
biological activities. 
Phytochemicals are natural bioactive compounds found in plants. They are 
mainly two groups, which are primary and secondary metabolites. Primary 
metabolites are sugars, amino acids, proteins and chlorophyll while secondary 
metabolites consist of alkaloids, terpenoids and phenolic compounds. The beneficial 
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metabolites present in the plant. So the systematic screening of plant species is 
necessary for the purpose of discovering new bioactive compounds. 
The phenolic compounds and flavonoids are secondary metabolites in plants 
having antioxidant activity. They have wide range of biological activities as cardio 
protection, cell proliferation and anti-aging. Tannins are potential toxic agents to 
fungi, bacteria and viruses in plants. They are currently investigated for human 
medicinal use, in order to reduce the risk of coronary heart diseases. 
6.8.2. Histamine aerosol induced bronchoconstriction in guinea pigs 
Histamine is one of the major inflammatory mediators in the immediate phase of 
asthma, causing airway hyper responsiveness and bronchial airway inflammation. 
Histamine induced bronchodialators is the traditional immunological model of antigen 
induced airway obstruction. Histamine when inhaled causes hypoxia and leads to 
convulsion in guinea pigs and causes very strong smooth muscle contraction, 
profound hypotension and capillary dialation in the cardiovascular system. A 
prominent effect caused by histamine leads to severe bronchoconstriction in the 
guinea pigs that causes convulsion and leads to death. Bronchodialators can delay 
the occurrence of these symptoms. In this histamine induced bronchospasm the 
ethanolic extract of the plant Alpinia calcarata rhizomes showed significant activity 
and increase in dose of extract increase % protection. The maximum % protection 
shown by the plant extract was 60.79 % observed at 200 mg/kg for bronchorelaxant 
study comparable to that of standard drug chlorpheniramine maleate 78.3 %. 
The results of the study confirmed the bronchodialotor properties of the plant, 
justifying its traditional claim in the treatment of asthma. 
6.8.3. Milk induced leukocytosis and eosinophilia 
In the present investigation ethanolic extract of the plant Alpinia calcarata rhizomes 
(100, 200 mg/kg) was evaluated for the management of asthma using milk induced 
leukocytosis and eosinophilia in mice. Asthma involves various types of mediator in 
pathology. It was demonstrated that potential administration of milk produces a 
marked increase in leukocytes and eosinophils count after 24 hours of its 
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administration. Leukocytes during asthmatic inflammation release the inflammatory 
mediators like cytokines, histamine and major basic protein, which promote the 
ongoing of inflammation. The infiltration of leukocytes potentiates the inflammatory 
process by the release of reactive oxygen species into the surrounding tissue, 
resulting in increased oxidative stress and associated with many pathological 
features of asthma. In this study we observed that leukocyte count was decreased in 
mice treated with ethanolic extract of plant at doses 100 and 200 mg/kg significantly 
as compared to control group. Results suggests that the ethanolic extract of the plant 
Alpinia calcarata rhizomes decreases milk induced leukocytes count by normalizing 
oxidative stress. An abnormal increase in peripheral eosinophil to more than 4% of 
total leukocytes count is termed as eosinophil. In asthmatic patient there is an 
increase in eosinophilic count and mucus hypersecretion and airway hyper reactivity 
were stimulated. Eosinophils infiltrating the airway also have an effect on mucus 
secretion by epithelial goblet cell. In our study it was observed that the ethanolic 
extract of Alpinia calcarata rhizomes at doses 100 and 200 mg/kg significantly 
decreased milk induced eosinophils count. 
The ethanolic extract of Alpinia calcarata rhizomes decrease the leukocyte 
count by normalizing oxidative stress and decrease in eosinophil count may reduce 
type I hypersensitivity in asthma. In conclusion ethanolic extract of the plant      
Alpinia calcarata rhizomes is effective in management of asthma. 
6.8.4. Isolated guniea pig tracheal preparation 
 It was observed that the ethanolic extract of Alpinia calcarata rhizomes inhibits 
contraction produced by histamine in these tissue preparations. Histamine (10 µg/ml) 
was taken in different dose level and concentration response curve was plotted. 
Study revealed that the ethanolic extract of the plant Alpinia calcarata rhizome exhibit 
significant percentage decreased contraction at concentration 0.8 mg/ml. 
6.8.5. Hydrogen peroxide scavenging 
The ethanolic extract of Alpinia calcarata rhizomes showed good dose 
dependent hydrogen peroxide scavenging activity. Hydrogen peroxide (H2O2), a 
biologically relevant, non- radical oxidizing species, may be formed in tissue through 
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oxidative processes. Although hydrogen peroxide is a weak oxidizing agent it can 
inactivate a few enzymes directly, usually by oxidation of essential thiol (-SH) groups. 
Hydrogen peroxide itself is not reactive, but can generate hydroxyl radical (OH) (via 
fenton reaction) in the cells resulting in initiation and propagation of lipid peroxidation. 
Thus the removal of H2O2 is very important for antioxidant defence in cell or food 
systems. Hydrogen peroxide can cross cell membranes and may oxidize a number of 
compounds. The ability of the extracts to quench OH- seems to be directly related to 
the prevention of the lipid peroxidation and appears to be moderate scavenger of 
active oxygen species, thus reducing rate of chain reaction. 
As a conclusion the ethanolic extract of the Alpinia calcarata rhizomes showed 
hydrogen peroxide activity as compared to standard ascorbic acid (100 µg/ml). 
6.8.6. Reducing power assay 
The reducing power of the extract, which may serve as a significant reflection 
of antioxidant activity, was determined using reducing power assay, where by the 
yellow colour of the test solution changes to various shades of green and blue is 
depending upon the reducing power of each compound. The presence of radicals (ie, 
antioxidant) causes the conversion of the Fe3+/ ferricyanide complex [Fe3+(CN-)6] 
used in this method to the ferrous form (Fe2+)/ ferrocyanide complex [Fe2+(CN-)6]. 
Therefore, by measuring the formation of Pearls Prussian blue 
spectrophotometrically, the Fe2+concentrationcan be monitored, a higher absorbance 
indicates a higher reducing power. The increased reducing power in the extracts 
indicates that some components in the extract were electron donors that could react 
with the free radicals to convert them into more stable products to terminate radical 
chain reaction. Antioxidant compounds are able to donate electrons to reactive 
radicals, reducing them into more stable unreactive species. 
The reducing power of the ethanolic extract of Alpinia calcarata rhizomes 
increased with increasing concentration. 
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6.8.7. Protein denaturation method 
Denaturation of protein is a well-documented cause of inflammation. 
Production of auto antigens may be due to the denaturation of tissue protein. Agents 
that can prevent protein denaturation therefore would be worthwhile for anti-
inflammatory drug development. The mechanism of denaturation probably involves 
the alteration electrostatic hydrogen, hydrophobic and disulphide bonding. It has 
been reported that one of the features of several non-steroidal anti-inflammatory 
drugs in their ability to stabilize heat treated protein at physiological pH. 
The ethanolic extract of the Alpinia calcarata rhizomes exhibited concentration 
dependant inhibition of protein denaturation. Therefore, from the study it can be 
concluded that the rhizomes of the plant extract possess marked in vitro anti-
inflammatory effect. 
6.8.8. Rabbit red blood cell membrane stabilization method 
The ethanolic extract of plant exhibit membrane stabilization property by 
inhibiting hypotonicity which effectively indicates the anti-inflammatory property. 
The viability of the cell depends up on the integrity of their membrane 
exposure of RBC to hypotonic medium, injurious substance results in the lysis of its 
membrane accompanied by haemolysis and oxidation of haemoglobin. Compounds 
with membrane stabilizing properties are well known for their ability to their ability to 
interfere with the early phase of inflammatory reactions. 
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Alpinia calcarata is a rhizomatous perennial herb belonging to family 
zingiberaceae. It was traditionally used for the treatment of asthma, bronchitis, 
rheumatoid arthritis, stomachic disease, diabetes and heart diseases. 
The study includes the phytochemical and pharmacological investigation of the 
ethanolic extract of Alpinia calcarata rhizomes. The powdered rhizomes were 
extracted by means of soxhlet using the solvent ethanol. 
Preliminary phytochemical screening revealed the presence of carbohydrate, 
cardiac glycoside, protein, alkaloids, steroids, flavonoids, tannins and phenolic 
compounds. These constituents may be represented the presence for biological 
activities of the plant. The acute toxicity study revealed that there is no mortality with 
the ethanolic extract of Alpinia calcarata rhizomes up to the dose level of             
2000 mg/kg. 
Asthma is an allergic disease with the utmost clinical and economic effect is 
an allergic and inflammatory outward sign of respiratory disorders. Asthma is a 
respiratory disease. The symptoms of bronchial asthma are characterized by wide 
blowout narrowing of the bronchial tube due to contraction of smooth muscle in 
replay to stimuli subsequently in the release of histamine. 
Bronchoconstriction induced by histamine is an immunological model of 
antigen induced airway obstruction. Histamine when inhaled causes hypoxia and 
leads to spasm in guinea pigs and causes very strong smooth muscle contraction 
and capillary dialation in cardiovascular system. Bronchodialators can delay the 
occurrence of these symptoms. The study revealed the H1 receptor antagonistic 
activity and support the plant by anti-asthmatic property. 
Herbal formulations used in the treatment of asthma include some anti-stress 
herbs to enable adoption to stress since excessive stress or nervous debility may 
aggravate symptoms of asthma. The normalization effect of an adaptogen can be 
observed in milk induced leukocytosis after administration of milk. Also eosinophil 
play a pivotal role in the pathogenesis of allergic disorders. The plant extract showed 
marked protection against eosinophil cell count, which is a hallmark of allergic 
asthma as compared to control group. The reduction in eosinophil count means 
inhibition in eosinophil cell recruitment and inhibition of interleukins such as IL-4, IL-5 
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and IL-13 which play important role in eosinophil cell count. So the milk induced 
leukocytosis and eosinophilic study revealed anti asthmatic property of the plant 
extract. 
Histamine contracts the tracheal-bronchial muscle of guinea pig, goat, horse, 
dog and man. Guinea pig trachea is used for the screening of anti-asthmatic activity. 
The H1 receptor after stimulation produces well-ordered dose related contraction of 
isolated guinea pig trachea. In current study Alpinia calcarata significantly inhibited 
histamine induced contraction of isolated guinea pig trachea preparation indicating its 
H1 receptor antagonist activity and supports anti asthmatic property of the plant. 
The antioxidant property was studied by hydrogen peroxide scavenging assay 
and reducing power assay. Hydrogen peroxide scavenging ability of ethanolic extract 
of Alpinia calcarata rhizomes revealed that the extract scavenge the hydrogen 
peroxide. However, the hydrogen peroxide scavenging ability was low comparing to 
standard (ascorbic acid). Reducing power of ethanolic extract of Alpinia calcarata 
rhizomes significantly increased with increasing concentration. 
The in vitro anti-inflammatory potential of ethanolic extract of Alpinia calcarata 
rhizomes had shown concentration dependent inhibition of protein denaturation, 
hypotonicity induced haemolysis of rabbit red blood cell membrane stabilization. 
CONCLUSION 
The result of the investigation showed that the ethanolic extract of          
Alpinia calcarata rhizomes possess anti asthmatic activity. The antioxidant and anti-
inflammatory property of the plant also supports its anti-asthmatic property. Drugs 
effective in asthma are mostly steroidal in nature. Phytochemical analysis showed 
presence of flavonoid and steroids. The anti-asthmatic property showed by the plant 
may be because of these chemical moieties. The results obtained in the study 
supports the traditional and also demands further research and to isolate and 
characterize active principles responsible for anti-asthmatic activity. 
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